Based on these findings, both natural and synthetic Nrf2 activators are being explored for the treatment of MASLD and MASH; however, due to their electrophilic nature, the potential side effects of Nrf2 activators cannot be overlooked (Arroyave-Ospina et al., 2021). Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.